Answers are grounded in this paper and cite their sources.
IgD myelomas constitute about 1% of myelomas, have worse prognosis, have higher association with lambda light chains, and are associated with excess free involved light chains. Standard immunofixation protocols stain only for IgG, IgM and IgA heavy chains. Proper attribution of a monoclonal gammopathy as having a delta heavy chain requires additional testing that is not available in most clinical laboratories. Retrospective review of protein electrophoresis and other laboratory results showed characteristic findings in IgD myelomas.
No takes yet. Share an insight, caveat, or question.
Singh Gurmukh (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: